Information Journal Paper
APA:
Copy. (2018). A developed antibody-drug conjugate rituximabvcMMAE shows a potent cytotoxic activity against CD20-positive cell line. ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY, 46(-), 1-8. SID. https://sid.ir/paper/734899/en
Vancouver:
Copy. A developed antibody-drug conjugate rituximabvcMMAE shows a potent cytotoxic activity against CD20-positive cell line. ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY[Internet]. 2018;46(-):1-8. Available from: https://sid.ir/paper/734899/en
IEEE:
Copy, “A developed antibody-drug conjugate rituximabvcMMAE shows a potent cytotoxic activity against CD20-positive cell line,” ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY, vol. 46, no. -, pp. 1–8, 2018, [Online]. Available: https://sid.ir/paper/734899/en